The promoter in HIV type 1 (HIV-1) proviral DNA contains three sequential guanosines at the U3-R boundary that have been proposed to function as sites for transcription initiation. Here we show that all three sites are used in cells infected with HIV-1 and that viral RNAs containing a single 5′ capped guanosine ( 
Strikingly, under physiological-like ionic conditions in which the
Cap 1G 5′-leader RNA adopts a dimeric structure, the Cap 2G and Cap 3G 5′-leader RNAs exist predominantly as monomers. Mutagenesis studies designed to probe for base-pairing interactions suggest that the additional guanosines of the 2G and 3G RNAs remodel the base of the PolyA hairpin, resulting in enhanced sequestration of dimerpromoting residues and stabilization of the monomer. Our studies suggest a mechanism through which the structure, function, and fate of the viral genome can be modulated by the transcriptionally controlled presence or absence of a single 5′ guanosine.
HIV-1 | 5′-leader | transcription | RNA | structure T he assembly of HIV type 1 (HIV-1) particles in infected cells is initiated by the transcription of viral RNA molecules encoded within integrated proviral DNA (1) . Like all eukaryotic cellular mRNAs, HIV-1 transcripts are cotranscriptionally capped by a 5′-5′ triphosphate-linked 7-methylguanosine (7MeG) moiety shortly after initiation of RNA polymerase II-dependent synthesis (2) (3) (4) (5) . Some transcripts undergo splicing to produce mRNAs that direct ribosomal synthesis of the viral envelope (Env) protein and accessory proteins, whereas others are not spliced and instead function as mRNAs for the viral Gag and, via frameshifting, the Gag-Pol polyproteins (1) . A subset of unspliced viral RNAs does not appear to function as mRNAs, instead being recognized by Gag proteins and incorporated into assembling virions. These RNAs serve as the viral genome (gRNA) and are used as templates for reverse transcription during an early stage of the replication cycle. gRNAs are selected for packaging as dimers (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) , enabling strand-transfermediated recombination during reverse transcription and facilitating genetic evolution under environmental and chemotherapeutic pressures (23) .
The current understanding of the factors that control the diverse functions of the viral genome is limited. However, the structure of the RNA itself, particularly the highly conserved 5′-leader (5′-L) (1, 24) , appears to play an important role. The HIV-1 5′-L contains discrete nucleotide sequences that are important for transcriptional activation (TAR), tRNA primer binding for initiation of reverse transcription (PBS), initiation of RNA dimerization (DIS), splicing (SD), and packaging (Ψ ) (Fig. 1) . Residues at the 3′ end of the 5′-L that overlap the gag gene start site (AUG) function in both translation and dimerization. Studies have shown that, in vitro, HIV-1 5′-L RNAs can exist as an equilibrium mixture of monomeric and dimeric species and that the equilibrium can be shifted by rational mutagenesis (25, 26) . Mutations that favor the monomeric fold in vitro also inhibit nucleocapsid (NC) protein binding, and vector RNAs with these mutations are unable to compete with wild-type 5′-L sequences for encapsidation into viruses (26) . Conversely, mutations that favor dimerization and NC binding in vitro also promote competitive RNA packaging (26) . These and other data collectively support models in which a single viral transcript directs multiple functions via a monomer-dimer RNA structural switch (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (25) (26) (27) (28) (29) (30) (31) (32) (33) .
To identify molecular determinants of retroviral RNA structure, we recently examined the dimerization properties of native and mutant 5′-L RNAs of several lentiviruses (31) . Unexpectedly, RNAs reported to start with three 5′ guanosines exhibited dimerization properties substantially different from those that begin with two guanosines. 5′-Capped HIV-1 transcripts that begin with one, two, or three 5′ guanosines (herein called " (4, (34) (35) (36) , which is defined genetically as the first residue in the repeat (R) element of the HIV-1
Significance
Current dogma states that the integrated HIV type 1 provirus encodes a single RNA transcript that serves as both mRNA for generating viral proteins and as genomic RNA that is packaged and used for reverse transcription. We now show that multiple transcripts with different functions are generated in infected cells, a consequence of heterogeneous transcriptional start site usage. Transcripts that begin with a single capped guanosine are specifically selected for packaging, whereas those that begin with two or three capped guanosines are enriched on polysomes and used for translation. In vitro studies with recombinant 5′-leader transcripts reveal a mechanism by which the incorporation of a single 5′ guanosine dramatically alters the structure, function, and fate of the viral RNA.
LTR (Fig. 1A) . HIV-1 proviruses typically contain a conserved stretch of three guanosines at the U3/R junction (LANL HIV sequence database), any of which potentially could function as the TSS. For the widely studied NL4-3 strain of HIV-1 (HIV-1 NL4-3 ), these residues correspond to G454, G455, and G456 of the proviral DNA and to residues −1, 1, and 2 of the transcribed RNA according to the traditional numbering for the HIV-1 5′-L RNA (Fig.  1A) . Early nuclease digestion experiments indicated that G454 serves as the TSS in HIV-1 NL4-3 (35) . However, subsequent primer extension experiments indicated that G455 serves as the TSS (34), and a more recent study that used RNA ligase-mediated 5′-RACE identified G456 as the TSS (4). However, a very recent study that also probed transcript 5′ ends by 5′-RACE indicated that all three start sites are used, but that only one transcript (1G) is enriched in virions and functions efficiently in reverse transcription (36) .
Here we used an RNase protection assay to probe for TSS use in cells and viruses and tested the selectivity of viral replication steps for specific RNA species among experimentally altered intracellular RNA populations. This approach has the advantage of avoiding the 5′-end deletions or additions that can be generated during 5′-RACE procedures and that were reported to occur in earlier studies (36) . Our findings confirm that all three transcripts are synthesized in cells and that the Cap 1G RNA is specifically selected for packaging. In addition, we now show that the Cap 2G and Cap 3G transcripts are enriched on polysomes, demonstrating that transcripts with different TSS have distinct functions. We also examined the effects of TSS selection and 5′ capping on the monomer-dimer equilibrium behavior of recombinant HIV-1 NL4-3 5′-L RNAs. In vitro, the 5′-L RNAs exhibit strikingly different behavior, with both the 1G and 2G RNAs favoring dimerization and the 3G RNA favoring the monomer. Thus the inclusion of a single 5′ guanosine is sufficient to alter RNA structure dramatically. Surprisingly, the influence of the 5′-Cap moiety on dimerization was similar to that of adding a single phosphodiester-linked 5′ guanosine. Our findings support proposals that genome dimerization is a major determinant of RNA function (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (25) (26) (27) (28) (29) (30) (31) (32) (33) and suggest a paradigm in which the structure, function, and fate of the viral transcripts are modulated by heterogeneous TSS selection.
Results
Heterogeneous HIV-1 TSS Use in Infected and Transfected Cells. The unexpected discovery of differing dimerization properties for 5′-L RNAs with different 5′ ends (see above) made identifying the authentic TSS used by replicating HIV-1 a priority. Because RNase protection assays yielded the cleanest results of several approaches tested here and were readily applicable to both in vitro-transcribed RNAs and samples extracted from viruses and cells, this approach was the primary method used for 5′-end determination. All approaches for determining 5′ ends are affected by the substrate preferences of analytic enzymes, and these and other experimental variables likely have contributed to the literature's conflicting reports about the 5′ ends of HIV-1 RNA. Therefore, to ensure the accuracy of the RNA-end assignments here, six in vitro-synthesized RNAs with known 5′ ends served as RNase protection assay controls to provide signatures for protected products of specific RNA 5′ ends (Fig. 1D) . These RNA standards were prepared by in vitro transcription and were capped using a recombinant Vaccinia virus capping enzyme (37, 38) .
RNase protection of the six in vitro-generated 5′-L RNAs yielded distinct protected products for the Cap 1G, Cap 2G, and Cap 3G RNAs (Fig. 1D, lanes 2, 4, and 6 ).
Cap

1G and
Cap 2G RNAs each generated a mixture of two protected products, likely reflecting partial base pairing or breathing between the Cap moiety and the riboprobe's corresponding cytosine residue (Fig. 1D, lanes 3 and  5) . With this demonstration that this riboprobe allowed accurate assignment of RNA 5′ ends that differed by a single base, studies with viral RNAs were begun. Note that, because the riboprobe used here (probe 1 in Fig. 1C ) was complementary to the native U3/R junction to avoid confounding signal from U3/R sequences near the 3′ end of viral RNAs, this probe could not distinguish uncapped 3G RNA from Cap 3G RNA (Fig. 1A) , and thus the 3G RNA and its capped derivative protected the same-length product (Fig. 1D, lanes 6 and 7) .
To define the 5′ ends of virus-generated RNAs, the mobilities of RNase protection products of cell and virus samples were compared with those of the 5′-end standards ( Fig. 1 D and E) . RNA samples were harvested from 293T cells transfected with the Envdeletion HIV-1 derivative NL4-3-GPP (39) and from virions produced by these cells. Analysis of these samples revealed that cell RNA appeared to contain a mixture of the (Fig. 1E, lane 4) . In contrast, protected products generated from NL4-3-GPP virion RNA resembled only the products of the Cap 1G standard (Fig. 1E, lanes 1 and 3) . Overexpression of HIV-1-derived plasmids in 293T cells, as used in these initial experiments, can generate viral phenotypes that differ from those observed during natural infection. Thus, to test whether findings with NL4-3-GPP expressed in 293T cells resembled those of infectious virus, we next assayed cell and viral samples from CEM-SS T cells supporting a spreading infection initiated by the HIV-1 molecular clone NL4-3 (Fig. 1F) . The results (lanes 1 and 2) confirmed a marked difference in HIV-1 cell and virion RNA populations, with an even more pronounced difference in RNA populations than observed for transiently transfected 293T cells.
Although our experiments do not rule out the possibility that 5′-end heterogeneity is caused by the presence of some noncapped RNAs, previous 5′-end-mapping studies failed to detect evidence for a decapped form of HIV-1 RNA in either cells or virions (4) . The possibility that HIV-1 transcription partially bypasses mechanisms evolved to promote capping (2) or that HIV-1 RNAs become decapped in cells or virions appears remote (4).
HIV-1 RNA Packaging Is Selective for Cap 1G RNAs. The data presented above showed that Cap 1G RNAs predominated in virions but also comprised a significant proportion of the intracellular species. Thus, it seemed possible that the prominence of these RNAs within virions might reflect their high intracellular prevalence rather than selectivity for a particular RNA species per se. To address this possibility, the intracellular distribution of HIV-1 RNA 5′-end classes was skewed by expressing NL4-3 GPP derivatives with altered numbers of guanosine residues (denoted "2G-GPP" and "4G-GPP" to indicate the subtraction or addition of a guanosine residue) ( Fig. 2A) at their U3/R junctions. To distinguish RNA 5′ ends from 3′ repeats in RNase protection assays, portions of the downstream LTR were replaced with a simian virus 40 polyadenylation (pA) signal. These constructs were assayed using a modified riboprobe capable of differentiating RNAs with up to five 5′-terminal guanosines (riboprobe 2 in Fig. 2B ). Virion and cell RNA populations for these derivatives were compared with native 3G GPP-pA (Fig. 2C) .
Consistent with a mechanism for TSS selection based in part on distance counting from upstream promoter elements, the RNAs generated in cells expressing 2G-GPP-pA included an RNA one base shorter than Cap 1G (Fig. 2C, lane 11) . Similarly, most intracellular RNA species produced by 4G-GPP-pA appeared to be one base longer than the corresponding products in cells expressing a native 3G genome (compare lanes 9 and 13). However, although the Cap 1G RNA was a relatively minor intracellular species when 2G or 4G vectors were expressed (lanes 11 and 13) , the Cap 1G RNA nonetheless was the predominant species in extracellular virions (lanes 12 and 14) . Interestingly, although virion production levels from 293T cells transiently transfected with 2G-GPP-pA, 4G-GPP-pA, and parental NL4-3-GPP-pA were indistinguishable, when these mutations were built into both LTRs of NL4-3 and equal amounts of virus were used to infect CEM-SS cells, both the 2G and 4G forms showed significant delay in a spreading assay.
Capped 2G/3G HIV-1 RNAs Are Enriched on Polysomes. The correlation between RNAs that preferentially adopted a packaging-competent fold and the RNA subpopulation that was enriched in virions ( Figs. 1 and 2 To test this hypothesis, a spreading infection using the HIV-1 molecular clone NL4-3 was established in CEM-SS T cells, and both infected cells and cell-free virions were harvested (Fig. 3) . Cells were lysed under conditions that stabilize polyribosomes and were fractionated on sucrose step gradients (Fig. 3) . This process yielded fractions containing material more buoyant than ribosomes (10 and 20% sucrose fractions), a fraction that likely includes ribosome subunits and some nonribosomal ribonucleoprotein complexes (30% sucrose fraction), and the major polysome-containing fraction (40% sucrose fraction; lane 12). Consistent with earlier results, virion RNA was dominated by Cap 1G RNA, whereas RNA harvested from unfractionated cells contained both 9-12) . However, in contrast to the nonpolysomal fractions, which display Cap 1G /total RNA ratios reminiscent of the total cell extract, RNAs in the polysomal fraction displayed a marked bias toward the nonpackaged longer RNAs.
Influence of TSS Selection and Capping on Dimerization. Because prior studies have established that genome dimerization likely controls packaging and other RNA-dependent functions (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (25) (26) (27) (28) (29) (30) (31) (32) (33) , we examined the influence of TSS use on the in vitro dimerization properties of the HIV-1 NL4-3 5′-L (Fig. 4A) . 1G, 2G, and 3G forms of the RNA were prepared by in vitro transcription, and their relative propensities to form dimers were determined by native gel electrophoresis after incubation under conditions of physiologicallike ionic strength (Materials and Methods). As shown in Fig. 4 , all existed as equilibrium mixtures of monomeric and dimeric species. However, although the 1G and 2G 5′-L RNAs adopted predominantly dimeric structures, the 3G 5′-L RNA existed predominantly as a monomer.
The dimerization propensities of 5′-capped forms of the above RNAs ( Cap 1G, Cap 2G, and Cap 3G 5′-L) were also determined. Interestingly, the influence of the Cap moiety was similar to that observed with the transcriptional inclusion of an additional 5′ guanosine. Thus, 5′-L RNAs containing two 5′ guanosines and no Cap (2G 5′-L) or one 5′ guanosine plus a Cap ( Cap 1G 5′-L) behaved similarly, both exhibiting strong propensities to form dimers. In contrast, RNAs that contain three 5′ guanosines or two 5′ guanosines plus a Cap exhibited similar propensities to form monomers (Fig. 4A ). These findings demonstrate that the presence of a single additional 5′ guanosine can strongly perturb the monomerdimer equilibrium of the HIV-1 5′-L and that a Cap moiety influences dimerization in a manner similar to that of a phosphodiesterlinked 5′ guanosine.
Probing the Mechanism of 5′ Guanosine-and Cap-Dependent Dimerization Control. To understand how the 5′ guanosine and 5′-Cap residues influence dimerization, we prepared a series of 5′-L RNAs with point mutations designed to stabilize the monomeric or dimeric conformers differentially. Experiments were guided by a recently proposed dimerization mechanism, in which the monomeric conformer is stabilized by U5:DIS base pairing that sequesters the DIS and dimerization is promoted by the formation of U5:AUG base pairs that displace and expose the DIS (Fig. 4B) (26) . Comparative studies were conducted with native and mutant forms of the 2G form of the 5′-L, which exists predominantly as a dimer under the ionic conditions used (Fig. 4D, lane 1) . The replacement of U103 by cysteine, designed to destabilize the lower PolyA stem (Fig. 4C, lane 2) , led to a significant equilibrium shift in favor of the monomer (Fig. 4D, lane 2) . The replacement of A59 by uracil (Fig. 4C, subpanel 3 ) also shifted the equilibrium toward the monomer (Fig. 4D, lane 3) . Moreover, the compensatory replacement of A59 by guanosine in the previously mutated U103C construct, designed to re-establish base pairing in the lower PolyA stem (Fig. 4C, subpanel 4) , resulted in an equilibrium shift back toward the dimer (Fig. 4D, lane 4) . These findings reveal that the propensity of the 5′-L RNA to adopt the monomeric Fig. 3 . Analysis of HIV-1 RNA forms associated with polyribosomes. RNase protection assay on cell lysate fractions from chronically infected CEM-SS cells, analyzed with riboprobe 1 (Fig. 1 ). Lane 1: undigested probe. Lane 2: size standards. Lanes 3-6: fragments protected by the indicated RNA standards. Lanes 7-8: fragments protected by chronically infected cell medium (virus) and total cell lysate. Lanes 9-12: probe fragments protected by RNA from 10, 20, 30, and 40% sucrose step gradient fractions. Mobilities of protected products from the 5′ and 3′ ends of viral RNA are indicated on the right. species is inversely correlated with the stability of the lower stem of the PolyA hairpin. Note that, although the mutagenesis results are compatible with the monomeric 5′-L model shown in Fig. 4B (26), they do not appear to be compatible with an alternative long-distance interactive model (28) in which all mutations but one (U103C) are predicted to reside in unstructured loops and have little influence on the equilibrium.
Discussion
Viruses often evolve genetic simplicity by diversifying the functions of individual molecules. A classic example has been the use by retroviruses of a single unspliced transcript not only as the genome in progeny virions but also as the mRNA for the viral structural proteins. Although much remains to be learned about the factors that modulate these functions, there is considerable biological and biophysical evidence that the bifurcation of retroviral RNA into genome and mRNA roles is dictated by dimerization-dependent structural changes (9, 12, 16, 26, 29) . When RNA mutations that destabilize the dimer-competent fold of the HIV-1 5′-L are reconstituted into viral genomes, and these are coexpressed with wild-type genomes, the mutant RNAs fail to compete with the wild-type RNA for packaging (26) . Similarly, mutations that prevent dimerization of the recombinant 5′-L RNA of the Moloney murine leukemia virus (MLV) block packaging (40) , suggesting that dimerization-dependent control mechanisms are conserved among evolutionarily distant retroviruses (40, 41) . MLV-derived vectors harboring monomer-stabilizing mutations remain unpackaged in the absence of competing wild-type leader RNAs (40) , whereas mutations that shift the equilibrium of the HIV-1 5′-L in favor of the monomer but do not prevent dimerization do not prevent the HIV-1 RNA from functioning as both genome and mRNA in the absence of wild-type competition (26, 39, 42) . These and other observations support a mechanism in which a single viral transcript equilibrates between structures associated with alternate replication functions (9, 12, 16, 26, 29) . In these models, the equilibration is not rate limiting, and HIV-1 RNA fates are sealed by the binding of alternate sets of proteins associated with differing replication roles (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) 33) .
The present findings suggest a modified paradigm in which the functions and fates of HIV-1 transcripts are encoded not by a preexisting monomer-dimer equilibrium but instead by the intrinsic propensities of RNAs with different 5′ ends to adopt a monomeric or a dimeric conformation preferentially. In this model, the differential propensity of the capped 1G transcript to dimerize and of the 2G/3G RNAs to remain monomeric establishes the function and fate of the transcripts, with the capped 1G RNAs being selected for packaging and functioning as gRNA and the capped 2G/3G RNAs preferentially accumulating on polysomes and functioning as mRNAs.
Our studies also show that destabilizing the lower stem of PolyA by mutagenesis can cause a dramatic equilibrium shift in favor of the monomer. Based on secondary structure analyses, we propose a model in which the overhanging 5′ guanosine in the 3G and Cap 3G transcripts [position (−1)] (Fig. 1B) remodels the lower stem of PolyA by base pairing with C58 (Fig. 4E) . Disruption of the C58-G104 base pair would enable G104 to form a new base pair with C262 of the DIS, thereby favoring the monomeric conformer by stabilizing the U5:DIS helix by ∼3-10 kcal/mol (Fig. 4E) (43) . Because the 5′-Cap and 5′-G moieties have similar influences on the monomer-dimer equilibrium, it seems plausible that the overhanging 5′ Cap of the Cap 2G transcript also stabilizes the monomer by interacting with C58 and disrupting the PolyA helix. This model is compatible with studies showing that deletion of the TAR or PolyA hairpins does not significantly affect 5′-L dimerization or vector packaging (39) , whereas mutations that open the lower helix of TAR inhibit both dimerization and packaging (44, 45) .
Our studies reveal that transcriptional addition of only a single guanosine to Cap 1G RNA can dramatically perturb the monomerdimer equilibrium in vitro, but the predominant species generated in cells and used in replication are the It is not unusual for polymerase II promoters to use multiple TSS (47) . A recent genome-wide study of mammalian promoter architecture by cap analysis of gene expression identified subsets of TATA-driven promoters, termed "twinned TSS promoters," that have two dominant start sites separated by 0-3 nt (48, 49) . Interestingly, those with adjacent dominant start sites display a GGG consensus sequence and weak TATA conservation, and those with TSS sites separated by a single nucleotide also exhibit a relatively strong GGG preference and strong TATA use (49) . Importantly, TSS use varied among cell types and between normal and tumoral cell lines, indicating that factors other than sequence are important for TSS selection (49, 50) . Thus it is conceivable that HIV-1 TSS use may be affected by intracellular conditions or change temporally during replication, enabling early production of the longer Cap 2G/ Cap 3G mRNAs used for viral protein synthesis followed by an increase in the production of Cap 1G gRNA transcripts relegated for packaging. Efforts to test this hypothesis are underway.
Materials and Methods
RNAs for in vitro dimerization studies were prepared by mutating a previously described plasmid containing the 2G 5′-L sequence (51) . In vitro transcription was performed using a method that inhibits self-templated run-on (51, 52) . The 5′-capped RNAs were prepared using a Vaccinia virus capping enzyme prepared in house with plasmid kindly provided by Stephen Cusack, European Molecular Biology Laboratory (EMBL), Grenoble, France (38) . Cells were propagated and treated and plasmids and RNAs for viral and cellular assays were prepared using modifications of previously described approaches (39) . Further details regarding the methods used can be found in SI Materials and Methods.
